Design of toxicokinetic studies
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Xenobiotica
- Vol. 20 (11) , 1187-1199
- https://doi.org/10.3109/00498259009046838
Abstract
1. Toxicokinetics is defined as pharmacokinetic studies in animals during actual toxicity studies or under conditions mimicking them (species, duration, dose level, etc.). 2. Toxicology studies require toxicokinetics to check whether systemic exposure reflects administered dose. In particular, it is important to know whether the absence of toxicity at a given dose is due to the innocuousness of the compound or to its poor bioavailability. 3. Pivotal toxicology studies may require different toxicokinetic support than that of early studies, as more is learnt of the compound and its metabolites. Considerations need to be placed on such factors as the choice of biological matrix for drug assay, the relevance of metabolites, and which dose levels require the most pharmacokinetic investigation.Keywords
This publication has 7 references indexed in Scilit:
- Distribution coefficient, a convenient term for the relation of predictable physico-chemical properties to metabolic processesXenobiotica, 1988
- Amiodarone and desethylamiodarone tissue uptake in rats chronically treated with amiodarone is non-linear with the doseJournal of Pharmacy and Pharmacology, 1987
- Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routesXenobiotica, 1987
- Pharmacokinetics and Toxicity TestingCRC Critical Reviews in Toxicology, 1984
- Amiodarone pharmacokineticsAmerican Heart Journal, 1983
- Kinetics of fenfluramine isomers in the ratEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- Dissolution and Absorption of Nipedipine from Nifedipine-Polyvinylpyrrolidone CoprecipitateDrug Development and Industrial Pharmacy, 1980